An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011 ...
Abstract Background Despite high vaccination coverage, infection with Bordetella pertussis is a current public health concern in the Netherlands and other European Union member states. Because surveillance data are subject to extensive under-ascertainment and under-reporting, incidence is difficult to determine. Our objective was to estimate the age-group specific incidence of symptomatic pertussis infection in the Netherlands over the period 2005–2011, using multi-parameter evidence synthesis. Methods Age-specific seroconversion probabilities were estimated for 2007 using Netherlands populati... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Datenquelle |
Erscheinungsdatum: | 2015 |
Verlag/Hrsg.: |
Figshare
|
Schlagwörter: | Medicine / Biotechnology / 80699 Information Systems not elsewhere classified / FOS: Computer and information sciences / 19999 Mathematical Sciences not elsewhere classified / FOS: Mathematics / Cancer / 110309 Infectious Diseases / FOS: Health sciences / 60506 Virology / FOS: Biological sciences / Computational Biology |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-29167073 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dx.doi.org/10.6084/m9.figshare.c.3596810.v1 |
Abstract Background Despite high vaccination coverage, infection with Bordetella pertussis is a current public health concern in the Netherlands and other European Union member states. Because surveillance data are subject to extensive under-ascertainment and under-reporting, incidence is difficult to determine. Our objective was to estimate the age-group specific incidence of symptomatic pertussis infection in the Netherlands over the period 2005–2011, using multi-parameter evidence synthesis. Methods Age-specific seroconversion probabilities were estimated for 2007 using Netherlands population data stratified by age-group and cross-sectional population-wide serosurvey (PIENTER-2) data, with a sero-diagnostic cut-off of 125 EU/ml as a proxy for recent infection. Symptomatic probabilities were derived from a study of household contacts and from PIENTER-2. The annual number of symptomatic infected (SI) persons was estimated using evidence synthesis methods in a Bayesian framework, by combining the estimated ...